Protocol registration and selective outcome reporting in recent psychiatry trials: New antidepressants and cognitive behavioural therapies

Acta Psychiatrica Scandinavica

Volumn 132, Issue 6, 2015, Pages 489-498

  Shinohara, K ^a   Tajika, A ^a   Imai, H ^a   Takeshima, N ^a   Hayasaka, Y ^a   Furukawa, T A ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antidepressive agents; Clinical trials; Cognitive therapy; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT;

COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIBLIOGRAPHY AS TOPIC; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES;

EID: 84983185959     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12502     Document Type: Article

References (44)

1. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-1389.
2. Song F, Parekh S, Hooper L, Loke YK, Ryder J. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:234.
3. Song F, Parekh S, Hooper L et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:1-193.
4. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989;81:107-115.
5. Tuner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260.
6. Tuner EH, Knoepflmacher D, Shapley L. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database. PLoS Med 2012;9:e1001189.
7. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 2008;5:e191.
8. Fletcher RH, Black B. "Spin" in scientific writing: scientific mischief and legal jeopardy. Med Law 2007;26:511-525.
9. Furukawa TA, Watanabe N, Omori IM, Montri VM, Guyatt GH. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA 2007;297:468-470.
10. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-2465.
11. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
12. Ioannidis JP. Why most discovered true associations are inflated. Epidemiology 2008;19:640-648.
13. de Angelis C, Drazen JM, Frizelle FA et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004;351:1250-1251.
14. Begg C, Cho M, Eastwood S et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-639.
15. Moher D, Schulz KF, Altmanl DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194.
16. Schulz KF, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in RCTs. Lancet 2010;375:1144-1146.
17. Bourton I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309.
18. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med 2011;364:852-860.
19. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012;307:1838-1847.
20. Turner L, Shamseer L, Altman DG et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012;11:MR000030.
21. Dwan K, Gamble C, Williamson PR et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One 2013;8:e66844.
22. Nankervis H, Baibergenova A, Williams HC, Thomas KS. Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review. J Invest Dermatol 2012;132:2727-2734.
23. Hannink G, Gooszen HG, Rovers MM. Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions. Ann Surg 2013;257:818-823.
24. Tyler KM, Normand SL, Horton NJ. The use and abuse of multiple outcomes in randomized controlled depression trials. Contemp Clin Trials 2011;32:299-304.
25. Milette K, Roseman M, Thombs BD. Transparency of outcome reporting and trial registration of randomized controlled trials in top psychosomatic and behavioral health journals: a systematic review. J Psychosom Res 2011;70:205-217.
26. Pinto RZ, Elkins MR, Moseley AM et al. Many randomized trials of physical therapy interventions are not adequately registered: a survey of 200 published trials. Phys Ther 2013;93:299-309.
27. Eyding D, Lelgemann M, Grouven U et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:c4737.
28. Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry 2010;196:173-178.
29. Watanabe N, Hunot V, Omori IM, Churchill R, Furukawa TA. Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatr Scand 2007;116:84-95.
30. Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH. A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression. Am J Psychiatry 2012;169:22-30.
31. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40:211-223.
32. National Institute for Health and Care Excellence (NICE). Treatment management of depression in adults, including adults with a chronic physical health problem. Clinical guidelines 90 and 91, 2009. Available from www.nice.org.uk/CG91 (accessed in January 2014).
33. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder, 3rd edn. APA, 2010.
34. Mathieu S, Bourton I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-984.
35. Bastelaar KM, Pouwer F, Cuijpers P, Ripe H, Snoek FJ. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2011;34:320-325.
36. Schramm E, Zobel I, Dykierek P et al. Cognitive behavioral analysis system of psychotherapy versus interpersonal psychotherapy for early-onset chronic depression: a randomized pilot study. J Affect Disord 2011;129:109-116.
37. Fortney JC, Pyne JM, Mouden SB et al. Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial. Am J Psychiatry 2013;170:414-425.
38. Guerdjikova AI, McElroy SL, Winstanley EL et al. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord 2012;45:281-289.
39. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev 2011;19:MR000031.
40. Dwan K, Altman DG, Clarke M et al. Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med 2014;11:e1001666.
41. Rosenthal R, Dwan K. Comparison of randomized controlled trial registry entries and content of reports in surgery journals. Ann Surg 2013;257:1007-1015.
42. Dwan K, Altman DG, Arnaiz JA et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3:e3081.
43. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158-166.
44. Khan NA, Lombeida JI, Singh M, Spencer HJ, Torralba KD. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Arthritis Rheum 2012;64:2059-2067.